MEDIA_REFRESH_DATA_PRESS_RELEASE
Media
U.S. News Room
Press Releases
Fri Nov 22 00:00:00 GMT-05:00 2024
NEW
Daiichi Sankyo Joins with LabCentral Community as Platinum Sponsor
Download
Wed Nov 13 00:00:00 GMT-05:00 2024
NEW
Daiichi Sankyo to Showcase TURALIO® Research in Patients with Tenosynovial Giant Cell Tumor at CTOS
Download
Tue Nov 12 00:00:00 GMT-05:00 2024
NEW
Datopotamab Deruxtecan New BLA Submitted for Accelerated Approval in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Download
Fri Nov 08 00:00:00 GMT-05:00 2024
NEW
ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
Download
Wed Oct 30 00:00:00 GMT-05:00 2024
NEW
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
Download
Tue Oct 01 00:00:00 GMT-05:00 2024
ENHERTU® Granted Priority Review in the U.S. for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Who Have Received at Least One Line of Endocrine Therapy
Download
Mon Sep 23 00:00:00 GMT-05:00 2024
Datopotamab Deruxtecan Final Overall Survival Results Reported in Patients with Metastatic HR Positive, HER2 Low or Negative Breast Cancer in TROPION-Breast01 Phase 3 Trial
Download
Tue Sep 17 00:00:00 GMT-05:00 2024
Patritumab Deruxtecan Demonstrated Statistically Significant Improvement in Progression-Free Survival Versus Doublet Chemotherapy in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer in HERTHENA-Lung02 Phase 3 Trial
Download
Sun Sep 15 00:00:00 GMT-05:00 2024
DS-9606 Shows Promising Preliminary Clinical Activity in Patients with Advanced Solid Tumors
Download
Fri Sep 13 00:00:00 GMT-05:00 2024
ENHERTU® Showed Substantial Clinical Activity in Patients with HER2 Positive Metastatic Breast Cancer and Brain Metastases
Download